We are looking for exclusive regional or local licensing and distribution rights for ethical pharmaceutical (Rx and OTC) and consumer health products in areas with a high, yet unmet need. We are interested in ready-to-market, finished products or innovative drug candidates in late-stage clinical development (clinical phase 3 for standard pharmaceuticals; phase 2 proof-of-concept for orphan drugs).